Part one:Diagnosis and Regional Lymphatic Metastasis Prediction of Resectable Esophageal Squamous Cell Carcinoma:Combination of Quantitative and Semi-quantitative Parameters Derived from Dynamic Contrast-enhanced Magnetic Resonance Imaging at 3.0 TObjective:To determine whether combination of quantitative and semi-quantitative parameters derived from dynamic contrast-enhanced magnetic resonance imaging?DCE-MRI?can help identify resectable esophageal squamous cell carcinoma?ESCC?and regional lymphatic metastasis.Methods:Thirty-nine patients with ESCC underwent DCE-MRI less than 2 weeks before surgery.Endothelial transfer constant(Ktrans),reflux rate(Kep),fractional extravascular extracellular space volume?Ve?and fractional plasma volume?Vp?of ESCC and normal esophagus were measured for quantitative analysis.Time to peak?TTP?,max concentration?MAX Conc?,Max Slope and area under the concentration-time curve?AUC?were calculated for semi-quantitative analysis.Statistical analysis was performed to determine feasibility of DCE-MRI to identify ESCC and lymphatic metastasis.Results:The Mann-Whitney U test revealed that Ktrans and Kep of esophageal cancer were higher whereas TTP was shorter compared with normal oesophagus(Ktrans:0.29±0.23 vs.0.18±0.24 ml/min,Kep:0.56±0.20 vs.0.22±0.15 ml/min,and TTP:2.36±0.54 vs.3.42±0.99 min;all P<0.05);and receiver operating characteristic?ROC?curve analysis showed that Kep was better than TTP or Ktrans for identifying ESCC?areas under ROC curve:0.903 vs.0.832 or 0.713?.Kep was higher and TTP was shorter in patients with lymphatic metastasis than without this metastasis?both P<0.05?,and TTP was better than Kep for predicting lymphatic metastasis?areas under ROC curve:0.696 vs.0.659?.The other parameters showed no differences between ESCC and normal esophagus or between statuses of lymphatic metastasis?all P>0.05?.Conclusions:Kep and TTP can aid identify ESCC and lymphatic metastasis.Part two: Whole-tumor Histogram Analysis of Pharmacokinetic Parameters from Dynamic Contrast-enhanced MRI in Resectable Esophageal Squamous Cell Carcinoma: A Preliminary Correlation study with Pathologic T stage and Lymphatic MetastasisObjective: To determine if pharmacokinetic parameters histograms of ESCC from DCE-MRI are related to pathologic T stage and lymphatic metastasis.Methods: This institutional review board-approved prospective study included 42 patients with biopsy-confirmed ESCC who underwent DCE-MRI.Histogram metrics?median,mean,standard deviation [SD],skewness,kurtosis and entropy?of whole-tumor pharmacokinetic parameters including endothelial transfer constant(Ktrans),reflux rate(Kep)and fractional extravascular extracellular space volume?Ve?of ESCC were generated from Omni-Kinetics software.Statistic analysis was performed to determine correlations of pharmacokinetic parameters histograms with pathologic T stage and lymphatic metastasis.Results: Mann-Whitney U tests revealed Ktrans?median,mean and SD?,Kep?SD and entropy?and Ve?median,mean and entropy?of stage T1/2 ESCC were lower compared with stage T3 disease?all Ps < 0.05?;and Ktrans?entropy?and Kep?median,mean,SD and entropy?were higher while Kep?skewness?was lower in tumors with lymphatic metastasis than without this metastasis?all Ps < 0.05?.Receiver operating characteristic?ROC?analysis demonstrated entropy of Ve could best distinguish stage T1/2 from stage T3 with a sensitivity of 0.86 and specificity of 0.62;and SD of Kep could best identify lymphatic metastasis with a sensitivity of 0.78 and specificity of 0.60.The other histograms of pharmacokinetic parameters showed no differences between T stages and between statuses of lymphatic metastasis?all Ps > 0.05?.Conclusions: Pharmacokinetic parameters histograms of ESCC obtained on DCE-MRI are associated with pathologic T stage and lymphatic metastasis. |